vs
Side-by-side financial comparison of First Seacoast Bancorp, Inc. (FSEA) and TScan Therapeutics, Inc. (TCRX). Click either name above to swap in a different company.
First Seacoast Bancorp, Inc. is the larger business by last-quarter revenue ($4.0M vs $2.6M, roughly 1.6× TScan Therapeutics, Inc.). First Seacoast Bancorp, Inc. runs the higher net margin — -2.4% vs -895.1%, a 892.7% gap on every dollar of revenue. On growth, TScan Therapeutics, Inc. posted the faster year-over-year revenue change (286.0% vs 20.6%). First Seacoast Bancorp, Inc. produced more free cash flow last quarter ($329.0K vs $-32.2M). Over the past eight quarters, First Seacoast Bancorp, Inc.'s revenue compounded faster (12.6% CAGR vs -9.7%).
Sterling Bancorp was an American regional bank holding company that owned Sterling National Bank. It merged into Webster Bank in February 2022.
TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel T cell receptor (TCR) immunotherapies for hard-to-treat cancers. Its proprietary platform identifies high-affinity naturally occurring TCRs targeting tumor antigens, with pipeline candidates spanning hematological malignancies and solid tumors, operating in the global oncology therapeutics market.
FSEA vs TCRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.0M | $2.6M |
| Net Profit | $-87.0K | $-23.0M |
| Gross Margin | — | — |
| Operating Margin | -3.1% | -929.4% |
| Net Margin | -2.4% | -895.1% |
| Revenue YoY | 20.6% | 286.0% |
| Net Profit YoY | 93.8% | 35.8% |
| EPS (diluted) | $-0.04 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.0M | $2.6M | ||
| Q3 25 | $4.0M | $2.5M | ||
| Q2 25 | $3.9M | $3.1M | ||
| Q1 25 | $3.5M | $2.2M | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $3.3M | $1.0M | ||
| Q2 24 | $5.9M | — | ||
| Q1 24 | $3.2M | — |
| Q4 25 | $-87.0K | $-23.0M | ||
| Q3 25 | $390.0K | $-35.7M | ||
| Q2 25 | $-545.0K | $-37.0M | ||
| Q1 25 | $-603.0K | $-34.1M | ||
| Q4 24 | $-1.4M | — | ||
| Q3 24 | $44.0K | $-29.9M | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $-1.2M | — |
| Q4 25 | -3.1% | -929.4% | ||
| Q3 25 | -5.2% | -1475.6% | ||
| Q2 25 | -13.7% | -1256.6% | ||
| Q1 25 | -17.9% | -1669.7% | ||
| Q4 24 | -23.5% | — | ||
| Q3 24 | -17.8% | -3109.8% | ||
| Q2 24 | 35.6% | — | ||
| Q1 24 | -24.8% | — |
| Q4 25 | -2.4% | -895.1% | ||
| Q3 25 | 9.8% | -1422.1% | ||
| Q2 25 | -14.1% | -1201.3% | ||
| Q1 25 | -17.1% | -1571.9% | ||
| Q4 24 | -46.9% | — | ||
| Q3 24 | 1.3% | -2849.1% | ||
| Q2 24 | 33.9% | — | ||
| Q1 24 | -36.1% | — |
| Q4 25 | $-0.04 | $-0.18 | ||
| Q3 25 | $0.08 | $-0.28 | ||
| Q2 25 | $-0.13 | $-0.28 | ||
| Q1 25 | $-0.14 | $-0.26 | ||
| Q4 24 | $-0.31 | — | ||
| Q3 24 | $0.01 | $-0.25 | ||
| Q2 24 | $0.42 | — | ||
| Q1 24 | $-0.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $152.4M |
| Total DebtLower is stronger | — | $32.5M |
| Stockholders' EquityBook value | $63.5M | $123.1M |
| Total Assets | $599.3M | $228.8M |
| Debt / EquityLower = less leverage | — | 0.26× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $184.5M | ||
| Q2 25 | — | $218.0M | ||
| Q1 25 | — | $251.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $271.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $32.5M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | — | $32.3M | ||
| Q1 25 | — | $32.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $30.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $63.5M | $123.1M | ||
| Q3 25 | $63.2M | $144.0M | ||
| Q2 25 | $60.8M | $176.7M | ||
| Q1 25 | $61.2M | $210.2M | ||
| Q4 24 | $62.0M | — | ||
| Q3 24 | $65.8M | $229.1M | ||
| Q2 24 | $64.5M | — | ||
| Q1 24 | $64.7M | — |
| Q4 25 | $599.3M | $228.8M | ||
| Q3 25 | $609.6M | $262.2M | ||
| Q2 25 | $604.8M | $298.6M | ||
| Q1 25 | $592.6M | $332.7M | ||
| Q4 24 | $580.8M | — | ||
| Q3 24 | $601.8M | $348.0M | ||
| Q2 24 | $601.7M | — | ||
| Q1 24 | $576.5M | — |
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $449.0K | $-32.0M |
| Free Cash FlowOCF − Capex | $329.0K | $-32.2M |
| FCF MarginFCF / Revenue | 8.1% | -1253.3% |
| Capex IntensityCapex / Revenue | 3.0% | 6.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | $-139.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $449.0K | $-32.0M | ||
| Q3 25 | $661.0K | $-32.5M | ||
| Q2 25 | $-151.0K | $-33.3M | ||
| Q1 25 | $573.0K | $-37.6M | ||
| Q4 24 | $-2.9M | — | ||
| Q3 24 | $289.0K | $-27.9M | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $-70.0K | — |
| Q4 25 | $329.0K | $-32.2M | ||
| Q3 25 | $640.0K | $-33.9M | ||
| Q2 25 | $-154.0K | $-34.5M | ||
| Q1 25 | $542.0K | $-39.1M | ||
| Q4 24 | $-3.3M | — | ||
| Q3 24 | $264.0K | $-29.3M | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-81.0K | — |
| Q4 25 | 8.1% | -1253.3% | ||
| Q3 25 | 16.0% | -1349.6% | ||
| Q2 25 | -4.0% | -1123.1% | ||
| Q1 25 | 15.4% | -1801.8% | ||
| Q4 24 | -99.0% | — | ||
| Q3 24 | 7.9% | -2792.0% | ||
| Q2 24 | -26.5% | — | ||
| Q1 24 | -2.5% | — |
| Q4 25 | 3.0% | 6.7% | ||
| Q3 25 | 0.5% | 56.8% | ||
| Q2 25 | 0.1% | 41.6% | ||
| Q1 25 | 0.9% | 70.6% | ||
| Q4 24 | 11.0% | — | ||
| Q3 24 | 0.7% | 130.6% | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.69× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.57× | — | ||
| Q2 24 | -0.70× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
